+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication



Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication



Virus Research 153(2): 269-276



Co-infection of human immunodeficiency virus (HIV) with malaria is one of the pandemic problems in Africa and parts of Asia. Here we investigated the impact of pyrimethamine (PYR) and two other clinical anti-malarial drugs (chloroquine [CQ] or artemisinin [ART]) on HIV-1 replication. Peripheral blood mononuclear cells (PBMCs) or MT-2 cells were infected with HIV(NL4.3) strain and treated with different concentrations of the anti-malarial drugs. HIV-1 replication was measured using p24 ELISA. We show that 10 μM CQ and ART inhibited HIV-1 replication by 76% and 60% in PBMCs, respectively, but not in MT-2 cells. In contrast, 10 μM PYR enhanced HIV-1 replication in MT-2 cells by >10-fold. A series of molecular mechanism studies revealed that PYR increased intracellular HIV gag proteins without affecting the promoter or the reverse transcriptase activity. The effect of PYR was independent of HTLV-1 produced by MT-2 cells. Of interest, PYR treatment led to S-phase accumulation and increased AZT and d4T antiviral activity by ∼ 4-fold. Taken together, we show that PYR significantly enhances HIV-1 replication by affecting the cellular machinery. Our results could be relevant for the management of malaria and HIV particularly in regions where HIV-1 and malaria epidemics overlap.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053084601

Download citation: RISBibTeXText

PMID: 20800626

DOI: 10.1016/j.virusres.2010.08.018


Related references

Experimental study of the anti malarial drug haloquine . III. A study of the possibility of inhibiting the development of chemoresistance to pyrimethamine through the combined use of haloquine and pyrimethamine. Med Parazitol Parazitarn Bolezni 34(4): 434-439, 1965

In vitro effects of anti malarial drug pyrimethamine-sulphadoxine and activated charcoal on rat ileal smooth muscle. Global Journal of Pure and Applied Sciences 9(2): 229-233, 2003

Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal. Malaria Journal 8: 118, 2009

Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate. Malaria Journal 12: 359, 2013

Does anti-malarial drug knowledge predict anti-malarial dispensing practice in drug outlets? A survey of medicine retailers in western Kenya. Malaria Journal 11: 263, 2012

Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication. Virus Genes 52(1): 22-28, 2016

A community-randomised evaluation of the effect of IPTi on anti-malarial drug resistance in southern Tanzania. 2013

Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria. British Journal of Clinical Pharmacology 80(4): 706-715, 2015

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum. Malaria Journal 9: 326, 2010

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action. Malaria Journal 13: 471, 2014

Resistance to pyrimethamine in the anti-malarial zone of Thies (Senegal). Medecine Tropicale 21: 876-878, 1961

In vitro evaluation of anti malarial drug combinations. Proceedings of the Helminthological Society of Washington 39(SPECIAL ISSUE): 292-297, 1972

The suppression of malarial parasitemia by pyrimethamine anti parasit in combination with dapsone anti parasit or sulphormethoxine anti parasit human plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine & Hygiene 63(2): 216-229, 1969

Evaluation of bioluminescence-based assays of anti-malarial drug activity. Malaria Journal 12: 58, 2013